PATENT CLAIM ANALYSIS

Application Number: 16184791
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "275000"]

Abstract:
The present invention relates to a freeze-dried (also called lyophilized) drug nanosuspension. The present freeze-dried drug nanosuspension composition has an acceptable stability of the particle size distribution during storage, including long term storage.

Claim (Index 25):
The freeze-dried nanosuspension as claimed  claim 24  wherein the drug is E-4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 98.0
- Lexical Diversity: 1.22581
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15204587', '15042282', '10538344', '12942930', '14676709']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7707271272182834
- 35 USC 102 Novelty (BERT): 0.6519761423531182
- Combined Prediction Score: 0.7588520287317668
- Mean Citation Score: 329.481934
- Max Citation Score: 669.7927
- Similarity Product: 581.5613732752503

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test